Cécile Ciangura

Cécile Ciangura

Auto-generated profile, based on publicly available information

Cécile Ciangura

Department of Nutrition, Pitié-Salpetrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2019 in Obesity Surgery
Verified
Journal Article
Closed access
BGBARIA-MAT Group
BARIA-MAT Group
CCCécile Ciangura
Cécile Ciangura
MCMuriel Coupaye
Muriel Coupaye
PDPhilippe Deruelle
Philippe Deruelle
GGGéraldine Gascoin
Géraldine Gascoin
JNJacky Nizard
Jacky Nizard

5 May 2023 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
JOJean-Michel Oppert
Jean-Michel Oppert
CCCécile Ciangura
Cécile Ciangura
ABAlice Bellicha
Alice Bellicha

11 July 2019 in BMC Medicine
Verified
Journal Article
Open access
PDF file
ODon behalf of the Monogenic Diabetes Study Group of the Société Francophone du Diabète
on behalf of the Monogenic Diabetes Study Group of the Société Francophone du Diabète
XDXavier Donath
Xavier Donath
CSCećile Saint-Martin
Cećile Saint-Martin
DDDanièle Dubois-Laforgue
Danièle Dubois-Laforgue
RRRamanan Rajasingham
Ramanan Rajasingham
CBChristine Bellanné-Chantelot
Christine Bellanné-Chantelot
Monogenic diabetes (MgD) accounts for 1–2% of all diabetes cases. In adults, MgD is difficult to distinguish from common diabetes causes. We assessed the diagnosis rate and genetic spectrum of MgD using next-generation sequencing in patients with late adolescence/adult-onset diabetes referred for a clinical suspicion of MgD. This cross-sectional study was performed in 1564 probands recruited in 116 Endocrinology departments. Inclusion criteria were the absence of diabetes autoantibodies, and at least two of the three following criteria: an age ≤ 40 years and a body mass index (BMI) < 30 kg/m2 at diagnosis in the proband or in at least two relatives with diabetes, and a family history of diabetes in ≥ 2 generations. Seven genes (GCK, HNF1A, HNF4A, HNF1B, ABCC8, KCNJ11, and INS) were analyzed. Variant pathogenicity was assessed using current guidelines. Pathogenic variants were identified in 254 patients (16.2%) and in 23.2% of EuroCaucasian patients. Using more stringent selection criteria (family history of diabetes in ≥ 3 generations, age at diabetes ≤ 40 years and BMI < 30 kg/m2 in the proband, EuroCaucasian origin) increased the diagnosis rate to 43%, but with 70% of the identified cases being missed. GCK (44%), HNF1A (33%), and HNF4A (10%) accounted for the majority of the cases. HNF1B (6%), ABCC8/KCNJ11 (4.4%), and INS (2.8%) variants accounted for 13% of the cases. As compared to non-monogenic cases, a younger age, a lower BMI and the absence of diabetes symptoms at diagnosis, a EuroCaucasian origin, and a family history of diabetes in ≥ 3 generations were associated with MgD, but with wide phenotype overlaps between the two groups. In the total population, two clusters were identified, that mainly differed by the severity of diabetes at onset. MgDs were more prevalent in the milder phenotypic cluster. The phenotypes of the 59 patients (3.8%) with variants of uncertain significance were different from that of patients with pathogenic variants, but not from that of non-monogenic patients. Variants of HNF1B and the K-ATP channel genes were more frequently involved in MgD than previously reported. Phenotype overlapping makes the diagnosis of MgD difficult in adolescents/adults and underlies the benefit of NGS in clinically selected patients.

29 January 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
DMDelphine Mitanchez
Delphine Mitanchez
CCCécile Ciangura
Cécile Ciangura
SJSophie Jacqueminet
Sophie Jacqueminet
Gestational diabetes (GDM) has deleterious effects on the offspring. Maternal obesity and excessive gestational weight gain (GWG), often associated with diabetes, also contribute to these adverse outcomes. Objectives: To assess the benefit for the offspring of maternal lifestyle interventions, including diets and physical activity, to prevent or to improve GDM and to limit excessive GWG. Method: Systematic review of meta-analyses published in English between December 2014 and November 2019. Results: Lifestyle interventions to reduce the risk of GDM reported a decreased risk of 15% to 40%, with a greater effect of exercise compared to diet. Combined lifestyle interventions specifically designed to limit GWG reduced GWG by 1.6 kg in overweight and obese women, and on average by 0.7 to 1 kg in all pregnant women. In these trials, adverse neonatal outcomes were poorly studied. Combined lifestyle interventions in women with GDM significantly reduced fetal growth. Altogether, lifestyle interventions reduced the risk of preterm birth and shoulder dystocia, but individually, diets or exercise alone had no effect on neonatal adverse outcomes. Conclusion: Specific maternal, neonatal and offspring benefits of lifestyle interventions during pregnancy to prevent or improve GDM control or to limit GWG still require clarification.

9 November 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
DMDelphine Mitanchez
Delphine Mitanchez
SJSophie Jacqueminet
Sophie Jacqueminet
SLSaid Lebbah
Said Lebbah
MDMarc Dommergues
Marc Dommergues
DHDavid Hajage
David Hajage
CCCécile Ciangura
Cécile Ciangura
Maternal nutritional and metabolic status influence fetal growth. This study investigated the contribution of gestational weight gain (GWG), gestational diabetes (GDM), and maternal obesity to birthweight and newborn body fat. It is a secondary analysis of a prospective study including 204 women with a pregestational body mass index (BMI) of 18.5–24.9 kg/m2 and 219 women with BMI ≥ 30 kg/m2. GDM was screened in the second and third trimester and was treated by dietary intervention, and insulin if required. Maternal obesity had the greatest effect on skinfolds (+1.4 mm) and cord leptin (+3.5 ng/mL), but no effect on birthweight. GWG was associated with increased birthweight and skinfolds thickness, independently from GDM and maternal obesity. There was an interaction between third trimester weight gain and GDM on birthweight and cord leptin, but not with maternal obesity. On average, +1 kg in third trimester was associated with +13 g in birthweight and with +0.64 ng/mL in cord leptin, and a further 32 g and 0.89 ng/mL increase in diabetic mothers, respectively. Maternal obesity is the main contributor to neonatal body fat. There is an independent association between third trimester weight gain, birthweight, and neonatal body fat, enhanced by GDM despite intensive treatment.

9 May 2019 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
ABAlice Bellicha
Alice Bellicha
CCCécile Ciangura
Cécile Ciangura
CRCélina Roda
Célina Roda
ATAdriana Torcivia
Adriana Torcivia
PPPierre Portero
Pierre Portero
JOJean-Michel Oppert
Jean-Michel Oppert